Henlius Delivers On Innovation Agenda In 2021

Revenue At The Chinese Firm Has Increased By 186.3% Year On Year

 
• By Chloe Kent
  
Green ascending arrow
Henlius is expanding beyond biosimilars to develop its own innovative biologic products • Source: Alamy

More from Earnings

More from Business